106 search results for: type 2 inflammation

The Weight of Breath: The Impact of Pediatric Asthma on Patients and Caregivers
Pulmonology
The Weight of Breath: The Impact of Pediatric Asthma on Patients and Caregivers
videoanimation

Learn about the multifaceted burden of uncontrolled pediatric asthma on patients and their caregivers.

View more
ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Dermatology
ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Podcast

Professor Lisa Beck explores the chronic and persistent burden of atopic dermatitis (AD) as well as the concept of early intervention in patients with AD.

View more
ADVENT On Air | Early Intervention and Disease Modification in Atopic Dermatitis
Dermatology
ADVENT On Air | Early Intervention and Disease Modification in Atopic Dermatitis
Podcast

Prof. Thomas Bieber explores early intervention and disease modification in atopic dermatitis.

View more
Expert Interview with Dr Jason Hawkes
Dermatology
Expert Interview with Dr Jason Hawkes
expert video

Join Dr. Hawkes as he discusses what burdens and challenges CSU patients might expect and help identify that there are immune functions responsible for their symptoms not an external cause.

View more
ADVENT at EADV 2024
Congress
25
September
2024
Congress
ADVENT at EADV 2024

Join ADVENT at EADV 2024 congress (European Academy of Dermatology and Venereology) for 2 educational symposia on type 2 inflammation in atopic dermatitis and bullous pemphigoid. Visit Booth #A13 to learn more about type 2 inflammatory skin diseases with ADVENT.

 

ADVENT at UEG Week 2024
Congress
12
October
2024
Congress
ADVENT at UEG Week 2024

Join ADVENT at UEG Week 2024 (United European Gastroenterology) for an educational symposium on type 2 inflammation in EoE. Visit Booth #25 to learn more about ADVENT.

UEG <b>2</b>0<b>2</b>5 | Bridging the Gap in EoE: Strategies for Seamless Transition of Care
Gastroenterology
UEG 2025 | Bridging the Gap in EoE: Strategies for Seamless Transition of Care
expert video

Profs. Greuter, Savarino, and Giordano discuss multidimensional EoE assessment, tailoring long-term care to patient needs, and recent clinical data.

View more
ADVENT Forum 2025 Event Page
Awareness Day
4
April
2025
Awareness Day
ADVENT Forum 2025 Event Page

From the April 2025 ADVENT Forum in Lisbon, Portugal, this event page serves to spotlight curated soundbites from dermatology and immunology experts that connect the evolving science of type 2 inflammation to clinical application.

ADVENT at ESPGHAN | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management
Congress
17
May
2024
Congress
ADVENT at ESPGHAN | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management

Join global experts Prof. Salvatore Oliva and Dr. Dhandapani Ashok for an educational symposium at ESPGHAN, as they discuss the burden and impact of underlying type 2 inflammation in eosinophilic esophagitis (EoE), and the importance of early diagnosis and management in pediatric patients.

UEG Upcoming Events Carousel Thumbnail
Congress
5
October
2025
Congress
ADVENT at UEG WEEK 2025 | Bridging the Gap in EoE: Innovative Strategies for Seamless Transition of Care

Join Thomas Greuter, MD, Edoardo Vincenzo Savarino, MD, PhD, and Carla Giordano, MD, PhD, for an educational symposium as they use a case-based approach to explore the impact of chronic type 2 inflammation in EoE and outline strategies for optimizing transition of care and monitoring disease progression.

The Benefits of Early Intervention in Reducing the Burden of Disease in Children With Atopic Dermatitis
On Demand
The Benefits of Early Intervention in Reducing the Burden of Disease in Children With Atopic Dermatitis

This page presents educational material, infographics, and video highlights from our recent ADVENT symposia, including the 2025 World Congress of Pediatric Dermatology (WCPD) in Buenos Aires, Argentina, exploring the pathophysiology of type 2 inflammation and atopic dermatitis, the burden of disease leading to cumulative life course impairment (CLCI), and the risk of the atopic march in pediatric patients with atopic dermatitis.